1. Home
  2. GALT vs BAND Comparison

GALT vs BAND Comparison

Compare GALT & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GALT
  • BAND
  • Stock Information
  • Founded
  • GALT 2000
  • BAND 2000
  • Country
  • GALT United States
  • BAND United States
  • Employees
  • GALT N/A
  • BAND N/A
  • Industry
  • GALT Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • GALT Health Care
  • BAND Technology
  • Exchange
  • GALT Nasdaq
  • BAND Nasdaq
  • Market Cap
  • GALT 86.0M
  • BAND 358.3M
  • IPO Year
  • GALT N/A
  • BAND 2017
  • Fundamental
  • Price
  • GALT $1.35
  • BAND $14.09
  • Analyst Decision
  • GALT Hold
  • BAND Hold
  • Analyst Count
  • GALT 1
  • BAND 5
  • Target Price
  • GALT N/A
  • BAND $21.00
  • AVG Volume (30 Days)
  • GALT 177.8K
  • BAND 267.0K
  • Earning Date
  • GALT 05-19-2025
  • BAND 05-07-2025
  • Dividend Yield
  • GALT N/A
  • BAND N/A
  • EPS Growth
  • GALT N/A
  • BAND N/A
  • EPS
  • GALT N/A
  • BAND N/A
  • Revenue
  • GALT N/A
  • BAND $751,695,000.00
  • Revenue This Year
  • GALT N/A
  • BAND $1.59
  • Revenue Next Year
  • GALT N/A
  • BAND $13.79
  • P/E Ratio
  • GALT N/A
  • BAND N/A
  • Revenue Growth
  • GALT N/A
  • BAND 18.51
  • 52 Week Low
  • GALT $0.73
  • BAND $11.33
  • 52 Week High
  • GALT $3.41
  • BAND $25.02
  • Technical
  • Relative Strength Index (RSI)
  • GALT 49.34
  • BAND 62.27
  • Support Level
  • GALT $1.26
  • BAND $11.93
  • Resistance Level
  • GALT $1.63
  • BAND $12.72
  • Average True Range (ATR)
  • GALT 0.12
  • BAND 0.45
  • MACD
  • GALT 0.02
  • BAND 0.30
  • Stochastic Oscillator
  • GALT 35.00
  • BAND 98.69

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

Share on Social Networks: